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6Background
 Health supply chain projects in 
Tanzania, Zambia
– SMS for Life
 ACT stock reporting by text message
– eZICS
 The “stockout eliminator”
 Proved it’s theoretically possible 
to get medicines to populations 
in sub-Saharan Africa
 So what’s inhibiting adherence?
7Research findings: example inhibitors
 “I lacked water for taking medicine”
 “We are poor, we can't afford most of the 
requirements. Sometimes we have single meal a 
day”
 “The side effects were a bit too much for me”
 “If you don’t have money you can just take some 
local medicine”
 “…too many [malaria] tablets. So I took my 
pawpaws that I heard about on the radio”
 “I feared for stigma… you are viewed in a 
different manner by community members”
 “I hate the bitterness and largeness of the tabs”
 “I stop when I feel better… I keep it just in case I 
get a recurrence of same symptom”
8Research findings: ORS inhibitors
 “One litre is too much so I take a spoon of 
ORS and put it in a glass of water”
 “My child is not able to drink the full litre in 
24 hours so I have to throw away the left over. 
It’s such a waste” 
 “I don’t know what is one litre”
 “I don’t have clean water at hand”
 “I just heat the water, it’s too costly to boil it 
for 15 minutes”
 “The product is disgusting and sometimes my 
child vomits it”
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What is adherence? And who’s to blame?
Change the
offering
Change the
patient
10
What can be done?
 Improved value propositions may include:
– Water with medicine
– Food with medicine
– Shorter regimens
– Relaxed scheduling constraints
– Clearer instructions
– Reduced tablet size
– Improved medicine taste
– Enhanced packaging appeal
– Clarification of instructions
– Reminders set in app based on barcode
 How many of those would we welcome as 
reverse innovations?
ORS results to date
New Indian ORS sachet       New Ugandan ORS sachet       New Nigerian co-pack
Opinions of 630 
caregivers in 3 
countries
Smaller sachets, 
orange-flavoured, 
with brighter and  
more attractive 
packs
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Conclusions
 Pharmaceutical manufacturers “…are 
going to be paid on patient outcomes”
– Joseph Jimenez, CEO of Novartis, 2013
 Which means improving adherence
 I am convinced that making medicines 
easier to consume can be a significant 
contributor
 Doing that for sub-Saharan Africa could 
benefit all of us
Shaping the Future
Thank you!
https://www.youtube.com/watch?v=34vVN574Zow
